Foresight director discloses initial FRSX holdings
Foresight Autonomous Holdings Ltd. director Moshe Scherf filed an initial statement of beneficial ownership.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
3
Rhea-AI Filing Summary
Foresight Autonomous Holdings Ltd. director Moshe Scherf filed an initial statement of beneficial ownership. He reports direct holdings of 150,000 Ordinary Shares and stock options to acquire 57,143 Ordinary Shares at an exercise price of $1.1200 per share, expiring in 2029.
Indirectly, through his spouse, he may be deemed to beneficially own additional Ordinary Shares and stock options, as well as American Depositary Receipts (ADSs), where one ADS represents 90 Ordinary Shares. Footnotes also note 75,000 RSUs vesting through July 1, 2027 and 1,128,571 RSUs vesting through January 1, 2029, each RSU convertible into one Ordinary Share.
Insider Trade Summary
7 transactions reported
Mixed
7 txns
Insider
Scherf Moshe
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Stock options (right to buy) | -- | -- | -- |
| holding | American Depositary Receipts | -- | -- | -- |
| holding | Stock options (right to buy) | -- | -- | -- |
| holding | Stock options (right to buy) | -- | -- | -- |
| holding | Stock options (right to buy) | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
Holdings After Transaction:
Stock options (right to buy) — 57,143 contracts (Direct);
American Depositary Receipts — 107,100 contracts (Indirect, See Footnote);
Stock options (right to buy) — 207,143 contracts (Indirect, See Footnote);
Ordinary Shares — 150,000 shares (Direct);
Ordinary Shares — 1,257,143 shares (Indirect, See Footnote)
Footnotes (9)
- F1. Includes (i) 75,000 ordinary shares, no par value per share, of the Issuer (the "Ordinary Shares") issuable upon the vesting of restricted share units ("RSUs") through July 1, 2027. Each RSU represents the right to receive one Ordinary Share.
- F2. Includes 1,128,571 Ordinary Shares issuable upon the vesting of RSUs through January 1, 2029.
- F3. The securities are owned by Sivan Siboni Scherf, Mr. Scherf's spouse, and, therefore, Mr. Scherf may be deemed to beneficially own securities owned by Mrs. Siboni Scherf, to the extent of his spouse's pecuniary interest therein. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
- F4. The options were granted with an exercise price of NIS 3.50 and have been converted based on the ratio of $3.119 as of March 16, 2026.
- F5. The options were granted on October 20, 2022 and fully vested as of September 30, 2025.
- F6. The Issuer's securities are listed as American Depository Shares ("ADS"), where one ADS represents 90 Ordinary Shares. Each ADS is convertible at any time, at the holder's election. The ADSs have no expiration date.
- F7. The options were granted on May 4, 2017 and fully vested as of January 1, 2020.
- F8. The options were granted on July 16, 2020 and fully vested as of December 31, 2022.
- F9. The options were granted on October 20, 2022 and fully vested as of December 31, 2025.
Key Figures
Direct Ordinary Shares: 150,000 shares
Direct stock options: 57,143 underlying shares
ADS underlying shares: 107,100 Ordinary Shares
+4 more
7 metrics
Direct Ordinary Shares
150,000 shares
Directly held by Moshe Scherf
Direct stock options
57,143 underlying shares
Stock options at $1.1200, expiring 2029-10-20
ADS underlying shares
107,100 Ordinary Shares
Indirect ADS interests, one ADS = 90 Ordinary Shares
Indirect Ordinary Shares
1,257,143 shares
Ordinary Shares indirectly owned, including 1,257,143 total shown
RSUs to 2027
75,000 RSUs
Ordinary Shares issuable on RSU vesting through July 1, 2027
RSUs to 2029
1,128,571 shares
Ordinary Shares issuable on RSU vesting through January 1, 2029
Option exercise price
$1.1200 per share
Stock options over Ordinary Shares
Key Terms
restricted share units ("RSUs"), American Depository Shares ("ADS"), pecuniary interest, beneficial ownership, +1 more
5 terms
pecuniary interest financial
"may be deemed to beneficially own securities ... to the extent of his spouse's pecuniary interest therein."
beneficial ownership financial
"The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
stock options (right to buy) financial
"security_title": "Stock options (right to buy)""
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the Form 3 filing by Moshe Scherf at FRSX show?
The Form 3 shows initial beneficial ownership by director Moshe Scherf in Foresight Autonomous. It lists his direct Ordinary Share holdings, stock options, RSUs, and indirect interests through his spouse, without reporting any new purchases or sales.
What indirect FRSX holdings are attributed to Moshe Scherf through his spouse?
The filing states certain securities are owned by Sivan Siboni Scherf, his spouse. Moshe Scherf may be deemed to beneficially own those securities to the extent of his pecuniary interest, but he disclaims beneficial ownership beyond that economic interest.
What are the key option terms disclosed for Moshe Scherf’s FRSX holdings?
The filing shows stock options over Ordinary Shares with a $1.1200 exercise price, some expiring on October 20, 2029. Footnotes describe earlier grants on specific dates and confirm these options have fully vested by stated vesting completion dates.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates